Skip to content

Company information lookup

INNATE IMMUNOTHERAPEUTICS LIMITED (IIL)

Development of a drug candidate to treat secondary progressive multiple sclerosis.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IIL 0.210 5% 0.200 0.210 0.200 0.210 0.200 81,700

INNATE IMMUNOTHERAPEUTICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IIL
Securities
Official Listing Date 23 December, 2013
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.innateimmuno.com
Registered Office Address Suite 4.01, 35 Lime Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 8003 3650
Head Office Fax (02) 9225 5050
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Michael Quinn (Non Exec. Chairman)
Mr Simon Wilkinson (Managing Director)
Mr Christopher Collins (Non Exec. Director)
Ms Elizabeth Hopkins (Non Exec. Director)
Mr Andrew Sneddon (Non Exec. Director)
Mr Jeff Carter (CFO)
Company Secretary Mr Andrew Cooke
Principal Activities Development of a drug candidate to treat secondary progressive multiple sclerosis.

INNATE IMMUNOTHERAPEUTICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
15/04/2014 asterix Phase 2B Trial on Track and on Budget 2 PDF
11/03/2014 asterix EU Radiation Patent 1 PDF
07/03/2014 asterix Response to ASX price and volume query 4 PDF
03/02/2014   Investor Roadshow Presentation 35 PDF
03/02/2014 asterix Newly Published MIS416 Therapy Validation in Animal Studies 16 PDF
31/01/2014 asterix Appendix 4C - Dec 2013 Quarterly Cash Flow Statement 6 PDF
07/01/2014   Becoming a substantial holder from AEF 4 PDF
24/12/2013   Initial Director's Interest Notice - Andrew Sneddon 2 PDF
24/12/2013   Initial Director's Interest Notice - Elizabeth Hopkins 2 PDF
24/12/2013   Initial Director's Interest Notice - Christopher Collins 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
16 Apr 2014 0.200 -4.76% 0.210 0.200 316,300
15 Apr 2014 0.210 0% 0.210 0.200 230,964
14 Apr 2014 0.210 0% 0.215 0.207 602,000
11 Apr 2014 0.210 5% 0.210 0.200 173,681
10 Apr 2014 0.200 -13.04% 0.215 0.180 131,880

* Volume of shares shown represents only those shares traded on ASX.

INNATE IMMUNOTHERAPEUTICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IIL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IIL

Warrants & Structured Products

No warrants & Structured Products are available over the security IIL

ASX CFDs

No Contracts For Differences are available over the security IIL